Plenary: Next Frontier, Sunday, Afternoon Session

5/5/2019

1:00 PM - 5:05 PM

Location: MCP: W375d

Moderator(s)

Anthony Atala, MD

Wake Forest School of Medicine

Presenter(s)

IC

Ilias Cagiannos, MD

The University of Ottawa

Slides
Jeremie Calais

UCLA
Sam Chang, MD

Patricia and Rodes Hart Chair of Urologic Surgery
Vanderbilt University Medical Center
MC

Mengxia Chen
JC

Jonathan Coleman, MD

Memorial Sloan Kettering Cancer Center
Simone Crivellaro, MD

University of Illinois at Chicago, College of Medicine

Slides
Ananias Diokno, MD

Department Head
Oakland University William Beaumont School of Medicine
James Eastham, MD

Memorial Sloan Kettering Cancer Center
SE

Scott Eggener, MD
Matthew Gettman, MD

Mayo Clinic
Guilherme Godoy, MD

Baylor College of Medicine
Howard Goldman, MD,FACS

Cleveland Clinic
Simon Hayward, PhD

NorthShore University HealthSystem
Andrei Iagaru

Stanford University

Slides
Rajiv Jayadevan, MD

UCLA

Moderator(s)

Christopher Kane, MD

University of California San Diego

Presenter(s)

Steven Kaplan, MD

Director
Icahn School of Medicine at Mount Sinai
Natasha Kyprianou, PhD

University of Kentucky
Massimo Lazzeri, MD

Humanitas Clinical Research Hospital / Humanitas University
Joon Yau Leong

Department of Urology, Thomas Jefferson University
Seth Lerner, MD, FACS

Baylor College of Medicine
SM

Scott MacDiarmid, MD

University of North Carolina
Eugene Shkolyar, M.D.

Stanford University
Neal Shore, MD, FACS

Carolina Urologic Research Center
David Staskin, MD

Tufts University School of Medicine
Arnulf Stenzl, MD

University of Tuebingen, Germany
Grant Stewart

University of Cambridge

Moderator(s)

CA

Christopher Amling, MD

Chairman, Department of Urology
Oregon Health & Science University
Ajay Nangia, MBBS, FACS

University of Kansas Health System

Presentations:

1:00 PM - 1:10 PM
Highlights: Benign Urologic Research
Simon William Hayward, PhD – North Shore Unv. Health System Research Inst.
1:10 PM - 1:19 PM
LBA-02: Late-Breaking Abstract: International Phase 3, Double-Blind, Placebo- and Active (Tolterodine)-Controlled Study to Evaluate the Safety and Efficacy of Vibegron in Patients with Symptoms of Overactive Bladder: EMPOWUR
David R. Staskin, MD
1:10 PM - 1:55 PM
Late Breaking Abstracts: Benign
Anthony Atala, MD – Wake Forest School of Medicine; Ajay Kumar Nangia, MBBS, FACS
1:19 PM - 1:28 PM
LBA-03: Late-Breaking Abstract: Efficacy and Safety of Mirabegron vs. Placebo Add-on Therapy in Men with Overactive Bladder Symptoms receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia (PLUS)
Steven Abraham Kaplan, MD – Icahn School of Medicine at Mount Sinai
1:28 PM - 1:37 PM
LBA-04: Late-Breaking Abstract: Intradetrusor Injection of Adult Muscle-Derived Cells for the Treatment of Underactive Bladder: Interim Report on Safety and Efficacy (NCT02463448)
Ananias C. Diokno, MD
1:37 PM - 1:46 PM
LBA-05: Late-Breaking Abstract: Treatment of Urinary Urgency Incontinence using a Novel Rechargeable SNM System: 6-month results of the ARTISAN-SNM Study
Howard B. Goldman, MD,FACS – The Cleveland Clinic
1:46 PM - 1:55 PM
LBA-06: Late-Breaking Abstract: 12-month Feasibility Data of a Fully-implanted, Nickel-sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence
Scott Avard MacDiarmid, MD
1:55 PM - 2:05 PM
Highlights: Urologic Oncology Research
Natasha Kyprianou, PhD
2:05 PM - 2:14 PM
LBA-08: Late-Breaking Abstract: Screening of BRCA2 Mutated Men for Detection of Prostate Cancer: Preliminary Results from a National High Volume Cancer Center
Massimo Lazzeri, MD
2:05 PM - 5:05 PM
Late Breaking Abstracts: Malignant
Christopher J. Kane, MD; Christopher Lee Amling, MD
2:14 PM - 2:23 PM
LBA-09: Late-Breaking Abstract: Darolutamide Delays Prostate-Specific Antigen Progression and Time to Next Anticancer Therapies in Patients with Nonmetastatic Castration-Resistant Prostate Cancer
Neal D. Shore, MD, FACS
2:23 PM - 2:32 PM
LBA-10: Late-Breaking Abstract: ARCHES – Efficacy of Androgen Deprivation Therapy with Enzalutamide or Placebo in Metastatic Hormone-sensitive Prostate Cancer: Prostate-specific Antigen Results
Arnulf Stenzl, MD
2:32 PM - 2:41 PM
LBA-11: Late-Breaking Abstract: PAIREDCAP Trial: Prospective Assessment of Image Registration in Diagnosis of Prostate Cancer
Rajiv Jayadevan, MD – Icahn School of Medicine at Mount Sinai
2:41 PM - 2:50 PM
LBA-12: Late-Breaking Abstract: CALGB 90203 (Alliance): Radical Prostatectomy with or without Neoadjuvant Chemohormonal Therapy in Men with Clinically Localized, High Risk Prostate Cancer
James A. Eastham, MD – Memorial Sloan-Kettering Cancer Center
2:50 PM - 2:59 PM
LBA-13: Late-Breaking Abstract: Improved Detection of Indeterminate Renal Mass Vascularity with Superb Microvascular Imaging
Joon Yau Leong
2:59 PM - 3:08 PM
LBA-14: Late-Breaking Abstract: Comprehensive Characterisation of Circulating Tumour DNA in Plasma and Urine of Patients with Renal Tumours: Results of the DIAMOND and MonReC Studies
Grant Stewart
3:08 PM - 3:17 PM
LBA-15: Late-Breaking Abstract: Renal Hypothermia during Partial Nephrectomy: A Randomized Controlled Trial
Ilias Cagiannos, MD
3:17 PM - 3:26 PM
LBA-16: Late-Breaking Abstract: Nephron-sparing Management of Low Grade (LG) UTUC with UGN-101 (mitomycin gel) for Instillation: The Olympus Trial Experience
Seth Paul Lerner, MD, FACS
3:26 PM - 3:35 PM
LBA-17: Late-Breaking Abstract: Multicenter Prospective Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients with High-Grade Upper Tract Urothelial Carcinoma
Jonathan Andrew Coleman, MD – Memorial Sloan-Kettering Cancer Center
3:35 PM - 3:44 PM
LBA-18: Late-Breaking Abstract: Preliminary Phase 2 Clinical Results of IL-15RαFc Superagonist N-803 with BCG in BCG-unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) Patients Demonstrates 82% CR of Carcinoma in situ (CIS)
Sam S. Chang, MD
3:44 PM - 3:53 PM
LBA-19: Late-Breaking Abstract: Phase II Trial of Estrogen Receptor Targeted Treatment of Non-Muscle Invasive Bladder Cancer with Tamoxifen
Guilherme Godoy, MD – Baylor College of Medicine
3:53 PM - 4:02 PM
LBA-20: Late-Breaking Abstract: Automated Cystoscopic Detection of Bladder Cancer using Deep-learning
Eugene Shkolyar, M.D.
4:02 PM - 4:11 PM
Abstract 19-1648: PSMA Uptake on 68Ga-PSMA-11-PET/CT Positively Corrects with Prostate Cancer Aggressiveness
Mengxia Chen
4:11 PM - 4:20 PM
LBA-21: Late-Breaking Abstract: 68Ga-PSMA-11 PET/CT Detects Prostate Cancer at Early Biochemical Recurrence with Superior Detection Rate and Reader Agreement when Compared to 18F-Fluciclovine PET/CT in a Prospective Head-to-Head Comparative Phase 3 Study
Jeremie Calais
4:20 PM - 4:29 PM
LBA-22: Late-Breaking Abstract: Prospective Evaluation of 18F- DCFPyL in Patients with Biochemically Recurrent Prostate Cancer
Andrei Iagaru
4:29 PM - 4:38 PM
LBA-23: Late-Breaking Abstract: Single Port Radical Prostatectomy versus Xi Multi-Port Radical Prostatectomy: A Human Factor Analysis
Simone Crivellaro, MD
4:38 PM - 4:47 PM
LBA-24: Late-Breaking Abstract: First Clinical Evaluation of a Novel Magnetic Retraction Device during Reduced Port Robotic Assisted Radical Prostatectomy (ClinicalTrials.gov NCT03624465)
Matthew Thomas Gettman, MD
4:47 PM - 4:56 PM
LBA-25: Late-Breaking Abstract: RESIST-PC Phase 2 trial: 177Lu-PSMA-617 Radionuclide Therapy for Metastatic Castrate-Resistant Prostate Cancer
Jeremie Calais
4:56 PM - 5:05 PM
LBA-26: Late-Breaking Abstract: Pivotal Trial of MRI-guided Transurethral Ultrasound Ablation in Men with Localized Prostate Cancer
Scott E. Eggener, MD